Cosentyx

Cosentyx (secukinumab) is classified as an immunosuppressant. Immunosuppressants are often used to suppress immune responses that can cause the inflammation associated with certain diseases. Cosentyx is used primarily in the treatment of plaque psoriasis. It has also been found to be effective in treating psoriatic arthritis and ankylosing spondylitis. The drug is administered via injection and must be refrigerated.

Because secukinumab has not been sufficiently tested with pregnant women, doctors may recommend that pregnant women do not take Cosentyx and that women do not become pregnant while taking it.